EE173 Cost-Effectiveness of Risdiplam for Patients with Types 1 - 3 Spinal Muscular Atrophy (SMA) in Francecost-Effectiveness of Risdiplam for Patients with Types 1 - 3 Spinal Muscular Atrophy (SMA) in France
Abstract
Authors
M Boussahoua CS Sutherland V Aponte Ribero R Enache K Le Lay C Le Dissez J Chevalier